The estrogen fenamortone refers to Estradiol Tablets/Estradiol Dydrogesterone Tablets Combination Pack, and it is usually not possible to discontinue the medication privately. Estradiol Tablets/Estradiol Dydrogesterone Tablets Combination Pack can be used for the treatment of perimenopausal syndrome caused by natural or postoperative menopause, and should be taken uninterruptedly for a period of 28 days. If the medication is discontinued privately it may lead to a sudden drop in hormone levels in the body, resulting in worsening of uncomfortable symptoms such as dizziness, insomnia, abnormal uterine bleeding and other symptoms. Headache, nausea, abdominal bloating and other uncomfortable symptoms may occur during the use of the drug. The drug should be contraindicated in the presence of a known or suspected history of breast cancer, estrogen-dependent malignancy, unexplained genital tract bleeding, active or recent arterial thromboembolic disease, and a history of acute liver disease. Regular physical examinations such as mammograms should be performed during the use of the drug. Note that the above medications should be used under the guidance of a doctor and avoid unauthorized use of the medication to avoid adverse effects. If persistent discomfort occurs after stopping the medication privately, it is recommended to consult a doctor in time to improve the relevant examination and follow the doctor’s instructions to standardize the treatment.